Jim Cramer Says “Own It, Don’t Trade It” as CVS Health Gains Momentum

insidermonkey.com · 2026-09-05

A caller on the September 2 episode of Mad Money noted that CVS Health Corporation (NYSE:CVS) is up 21% this year, sports a 3% dividend, and trades at a 28 valuation compared to its 54 average.

TickrTrends take: CVS Health currently trades at a valuation that TickrTrends classifies as overvalued within the Healthcare sector, which creates a tension with commentary suggesting the stock warrants a longer-term holding approach. Investors focused on valuation metrics should monitor whether CVS's operational momentum can narrow the gap between its current trading price and fundamental value, or whether the overvaluation assessment reflects a disconnect between near-term business performance and longer-term value creation. The Healthcare sector's dynamics and CVS's competitive position will be important factors in determining whether current price levels become justified over time.

Read the full story at insidermonkey.com →